Growth Metrics

Vericel (VCEL) Property, Plant & Equipment (Net) (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Vericel 1.69 Bn 1.55 Bn 49.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.18%
Dec 31, 2025 -0.90%
Sep 30, 2025 -0.43%
Jun 30, 2025 1.43%
Mar 31, 2025 4.98%
Dec 31, 2024 16.68%
Sep 30, 2024 20.97%
Jun 30, 2024 29.60%
Mar 31, 2024 35.44%
Dec 31, 2023 37.79%
Sep 30, 2023 29.08%
Jun 30, 2023 28.64%
Mar 31, 2023 14.90%
Dec 31, 2022 -0.51%
Sep 30, 2022 -0.01%
Jun 30, 2022 10.16%
Mar 31, 2022 8.59%
Dec 31, 2021 12.60%
Sep 30, 2021 11.61%
Jun 30, 2021 16.68%
Mar 31, 2021 18.90%
Dec 31, 2020 7.28%
Sep 30, 2020 1.07%
Jun 30, 2020 -5.16%
Mar 31, 2020 3.91%
Dec 31, 2019 -0.64%
Sep 30, 2019 3.26%
Jun 30, 2019 8.04%
Mar 31, 2019 9.13%
Dec 31, 2018 13.42%
Sep 30, 2018 11.43%
Jun 30, 2018 11.08%
Mar 31, 2018 3.34%
Dec 31, 2017 2.62%
Sep 30, 2017 13.57%
Jun 30, 2017 -3.99%
Mar 31, 2017 -6.12%
Dec 31, 2016 -8.07%
Sep 30, 2016 -3.13%
Jun 30, 2016 -0.96%
Mar 31, 2016 8.50%
Dec 31, 2015 -6.16%
Sep 30, 2015 -6.52%
Jun 30, 2015 33.95%
Mar 31, 2015 19.16%
Dec 31, 2014 20.60%
Sep 30, 2014 0.46%
Jun 30, 2014 271.81%
Mar 31, 2014 -13.13%
Dec 31, 2013 -12.13%
Sep 30, 2013 -11.75%
Jun 30, 2013 -9.75%
Mar 31, 2013 -11.11%
Dec 31, 2012 -4.65%
Sep 30, 2012 -4.81%
Jun 30, 2012 -10.77%
Mar 31, 2012 -6.20%
Dec 31, 2011 4.69%
Sep 30, 2011 18.67%